Breast cancer (early) - hormonal treatments
Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer
Summary
Anastrozole, exemestane and letrozole are recommended as possible treatments for women who have a type of breast cancer called early oestrogen-receptor-positive breast cancer and have been through the menopause. Anastrozole, exemestane or letrozole may be given as an 'extra' treatment (called an adj ...
Guidance documents
Implementing this guidance
We will consult on our review plans for this guidance in June 2009
About this guidance
Technology appraisals TA112
Issued: November 2006